Home › Funds › Vestal Point Capital, LP › IRON
Vestal Point Capital, LP position in IRON
DISC MEDICINE INC · Health Care
Vestal Point Capital, LP reported holding 1,550,000 shares of IRON (DISC MEDICINE INC) in its Q2 2026 13F filing — a position valued at US$113.4M, representing 2.65% of its reported portfolio and ranking #12 among its reported holdings. Vestal Point Capital, LP has disclosed IRON holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's IRON position evolved
Vestal Point Capital, LP first disclosed a stake in IRON in Q2 2025 at 140,000 shares (US$7.4M). The position peaked in Q2 2026 at 1,550,000 shares, worth US$113.4M. Across 5 filings, Vestal Point Capital, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,550,000 shares valued at US$113.4M — an increase of 850,000 shares quarter over quarter.. Notable position changes include a 257% increase in Q3 2025 (shares rose 20% over the following quarter), a 47% increase in Q4 2025 (shares fell 19% over the following quarter), a 121% increase in Q2 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 140.00K | $7.41M | New |
| Q3 2025 | 500.00K | $33.04M | Add |
| Q4 2025 | 735.00K | $58.37M | Add |
| Q1 2026 | 700.00K | $44.76M | Reduce |
| Q2 2026 | 1.55M | $113.37M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRON and 13F data
IRON (DISC MEDICINE INC) is a Health Care company. 41 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Atlas Venture Life Science Advisors, LLC (US$110.7M), Frazier Life Sciences Management, L.P. (US$99.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRON
- RA CAPITAL MANAGEMENT, L.P. 2.45M sh · $179.21M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.51M sh · $110.72M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M sh · $99.09M · Q2 2026
- TCG Crossover Management, LLC 1.34M sh · $98.14M · Q2 2026
- BVF INC/IL 1.15M sh · $84.38M · Q2 2026
- Siren, L.L.C. 888.40K sh · $64.98M · Q2 2026
- Logos Global Management LP 875.00K sh · $64.00M · Q2 2026
- Opaleye Management Inc. 855.00K sh · $62.53M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K sh · $48.05M · Q2 2026
- Bellevue Group AG 560.00K sh · $40.96M · Q2 2026
- Saturn V Capital Management LP 524.73K sh · $38.38M · Q2 2026
- ARMISTICE CAPITAL, LLC 460.00K sh · $33.64M · Q2 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held IRON?
Vestal Point Capital, LP has disclosed IRON holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Vestal Point Capital, LP's current position in IRON?
As of Q2 2026, Vestal Point Capital, LP holds 1.55M shares of IRON (DISC MEDICINE INC), valued at $113.37M, representing 2.65% of its reported portfolio and ranking #12.
Has Vestal Point Capital, LP been buying or selling IRON?
In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in IRON. The position peaked in Q2 2026 at 1.55M shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, Frazier Life Sciences Management, L.P., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.